Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4M Buy
181,050
+100,220
+124% +$11.6M 3.23% 17
2026
Q1
$9.66M Buy
+80,830
New +$10.6M 1.58% 23
2015
Q3
Sell
-700,150
Closed -$26M 30
2015
Q2
$26M Buy
700,150
+7,050
+1% +$256K 5.15% 9
2015
Q1
$24.3M Buy
693,100
+160,150
+30% +$5.65M 4.89% 11
2014
Q4
$20.3M Buy
532,950
+72,050
+16% +$2.64M 4.08% 16
2014
Q3
$16.4M Buy
460,900
+123,000
+36% +$4.57M 3.43% 19
2014
Q2
$13.2M Buy
+337,900
New +$12.6M 2.66% 20
2013
Q3
Sell
-642,500
Closed -$17.3M 33
2013
Q2
$17.3M Buy
+642,500
New +$17.7M 4.03% 14

Other funds holding XYL

Dudley & Shanley's XYL Position: Q2 2026 in Review

Dudley & Shanley increased its Xylem (XYL) stake by 124% in Q2 2026, buying an estimated $11.6M and bringing the position to 181,050 shares worth $21.4M. The position accounts for 3.23% of the portfolio, ranked #17.

Dudley & Shanley first reported a position in XYL in Q2 2013 and has held it in 8 quarters since. The position peaked at $26M in Q2 2015. 166 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Dudley & Shanley held 181,050 shares of Xylem worth $21.4M as of Q2 2026.
  • Dudley & Shanley bought 100,220 Xylem shares in Q2 2026, an estimated $11.6M.
  • Xylem made up 3.23% of Dudley & Shanley's portfolio in Q2 2026, its #17 holding.
  • Dudley & Shanley first reported a position in Xylem in Q2 2013 and has held it in 8 quarters since.
  • Dudley & Shanley's Xylem position peaked at $26M in Q2 2015.
  • 166 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Dudley & Shanley's 13F filing for Q2 2026, filed 9 Jul 2026.